Does Insurance Cover TMS Therapy in Texas? A Houston Psychiatrist Explains

By William K. Drell, MD
Board-Certified Psychiatrist
Houston West TMS · October 2026

One of the first questions patients ask me about Transcranial Magnetic Stimulation (TMS) is:

“Will my insurance pay for it?”

For many patients, the answer is yes.

TMS is an established treatment option for major depressive disorder. Many commercial insurance plans and Medicare provide coverage when their medical-necessity requirements are met.

However, coverage is not automatic. Requirements vary by insurer and by individual plan.

At Houston West TMS, we currently participate with Blue Cross Blue Shield, Aetna, Medicare, Carelon and UnitedHealthcare. This includes many PPO plans and a more limited number of HMO plans.

Because benefits and networks vary, our office verifies each patient’s coverage and authorization requirements whenever possible.

Key Takeaways

• Many insurance plans and Medicare may cover TMS.
• Requirements vary by insurer and individual plan.
• Previous antidepressant treatment is commonly required.
• A denial does not always mean the process is over.
• Our office can help verify benefits and pursue authorization.
• Self-pay treatment is available for appropriate patients.

What Does Insurance Usually Require Before Covering TMS?

Most insurance companies require documentation that a patient has major depressive disorder (MDD) and has not improved adequately with previous treatment.

Depending on the plan, the insurer may require:

• A diagnosis of major depressive disorder
• Documentation of the current episode’s severity and duration
• Previous antidepressant trials
• The dose and length of each medication trial
• Inadequate response, partial response or medication intolerance
• A standardized depression rating scale, such as the PHQ-9
• Previous psychotherapy
• Previous medication augmentation
• Documentation that TMS is medically appropriate and safe

Not every plan requires all of these items.

Insurance policies can also change. That is why checking the specific plan is more reliable than relying on general information about an insurance company.

How Many Antidepressants Do You Have to Try Before Insurance Covers TMS?

There is no universal number.

Historically, some insurers required patients to try numerous medications, psychotherapy and augmentation strategies before authorizing TMS.

Fortunately, I have seen this gradually change.

Some insurers now require fewer antidepressant trials. Others have reduced or eliminated requirements for specific augmentation medications or psychotherapy.

For example, current Medicare coverage criteria applicable in Texas provide coverage for appropriately selected patients with severe major depressive disorder who meet the Medicare contractor’s medical-necessity requirements. These requirements include inadequate response to previous pharmacologic treatment.

Commercial insurance plans may be more restrictive.

In my practice, I commonly begin discussing TMS after a patient has not responded adequately to, or has been unable to tolerate, antidepressants from at least two different medication classes.

The decision is always individualized.

Insurance requirements determine whether an insurer will pay for TMS. They do not necessarily determine whether TMS is medically appropriate for a particular patient.

Why Are Some Insurance Requirements Becoming Less Restrictive?

This is an encouraging development.

In the past, patients could be required to continue trying medication after medication—or add additional medications—before insurance would authorize TMS.

Some augmentation strategies include medications such as:

• Lithium
• Lamotrigine (Lamictal)
• Aripiprazole (Abilify)
• Cariprazine (Vraylar)
• Quetiapine (Seroquel)
• Lumateperone (Caplyta)

These medications can be appropriate and helpful for selected patients. However, all medications have potential risks and side effects.

Depending on the medication, these may include weight gain, metabolic changes and other adverse effects. Certain dopamine-blocking medications can also cause tardive dyskinesia, an involuntary movement disorder that can sometimes persist.

I do not believe a patient should take an additional medication solely to satisfy an insurance requirement when that medication is not clinically appropriate.

Reducing unnecessary prerequisites may allow appropriate patients to consider TMS sooner.

Does Medicare Cover TMS in Texas?

Yes, Medicare may cover TMS for appropriately selected patients who meet its coverage requirements.

Texas is within the Medicare jurisdiction administered by Novitas Solutions. Its current Local Coverage Determination provides coverage criteria for TMS in adults with severe major depressive disorder.

Medicare coverage still depends on several factors, including:

• The diagnosis
• Previous treatment history
• Medical necessity
• Safety considerations
• Applicable Medicare requirements

Medicare policies can change. Eligibility should therefore be verified for each patient.

What About Blue Cross Blue Shield, Aetna, UnitedHealthcare and Carelon?

Houston West TMS currently participates with Blue Cross Blue Shield, Aetna, Medicare, Carelon and UnitedHealthcare.

This includes many PPO plans and a more limited selection of HMO plans.

Coverage requirements vary.

Two patients may carry insurance cards from the same company but have different:

• Benefits
• Provider networks
• Deductibles
• Copayments
• Coinsurance
• Prior-authorization requirements

That is why we verify the patient’s specific plan rather than simply saying, “Yes, we take that insurance.”

Our office can help determine:

• Whether Houston West TMS participates with the specific plan
• Whether the plan includes TMS benefits
• Whether prior authorization is required
• What clinical documentation is needed
• The deductible, copayment or coinsurance when available
• Whether additional information is needed before authorization

What Does Houston West TMS Do for Prior Authorization?

Patients should not have to navigate the TMS authorization process alone.

Our office reviews and helps document the patient’s treatment history, including:

• Previous antidepressants
• Medication doses when available
• Treatment duration
• Clinical response
• Medication intolerance
• Psychotherapy history
• Augmentation history when required

We can also help obtain or coordinate medical records, communicate with the insurance company, submit documentation and respond to requests for additional information.

If an authorization is denied and I believe TMS remains clinically appropriate, we may appeal the decision and provide additional clinical information supporting the request.

Not every denial can be overturned. However, an initial denial does not necessarily end the process.

Why Does Insurance Sometimes Deny TMS?

There are several possible reasons.

An insurer may determine that:

• The diagnosis does not meet the plan’s requirements
• There have not been enough medication trials
• A medication was not taken at an adequate dose
• A medication was not taken for the required length of time
• Required psychotherapy was not documented
• Required augmentation was not documented
• Symptoms do not meet the plan’s severity threshold

Some plans also require a particular score on a standardized depression scale, such as the PHQ-9.

In clinical practice, however, a patient with a lower score may still have significant depression—especially when symptoms have persisted despite previous treatment.

This is an important distinction:

Insurance criteria determine whether a plan will pay. They do not, by themselves, determine whether TMS may be clinically reasonable.

Can Bipolar Disorder Affect TMS Insurance Coverage?

Yes.

The FDA-cleared indication and many insurance policies for TMS depression treatment are based on major depressive disorder.

A diagnosis of bipolar disorder may therefore affect whether an insurer authorizes TMS under its depression policy.

That does not mean every patient with a complicated mood-disorder history should automatically be excluded from consideration.

I personally perform a comprehensive psychiatric evaluation before recommending TMS. This helps confirm the diagnosis and determine whether TMS is clinically appropriate.

Distinguishing unipolar major depression from bipolar depression is especially important before beginning treatment.

What About Seizures, Pacemakers or Other Implanted Devices?

A history of seizures, metal near the head, a pacemaker or another implanted electronic or medical device requires careful evaluation before TMS.

Several factors matter, including:

• The type of device
• Its location
• The patient’s medical history
• The TMS equipment being used

Insurance companies may also have their own safety exclusions or authorization criteria.

These situations should be evaluated individually. A remote seizure history or implanted device does not automatically make TMS impossible in every circumstance.

Patient safety comes first.

Does a PHQ-9 Score Determine Whether Someone Can Receive TMS?

Not by itself.

The PHQ-9 is a useful questionnaire for measuring depressive symptoms and tracking changes during treatment.

Some insurance plans require a specific PHQ-9 score or another depression-rating-scale threshold. In our experience, some plans may require a score in the severe range, such as 17 or higher.

Clinically, however, the PHQ-9 is only one part of the evaluation.

A patient with a score of 10 or greater may still have meaningful depression, particularly when symptoms are persistent and previous treatments have failed or caused significant side effects.

I evaluate the entire clinical picture rather than making a treatment recommendation based on one number.

Does FDA Clearance Automatically Mean Insurance Will Pay?

No.

FDA clearance and insurance coverage are separate issues.

FDA clearance establishes that a device may be marketed for a particular indication. Insurance coverage depends on the patient’s benefit plan and the insurer’s medical-necessity requirements.

An insurance company may impose requirements that are more restrictive than the FDA-cleared indication.

Similarly, a treatment may be medically reasonable for a particular patient even when that patient’s insurance plan will not pay for it.

What Happens if Insurance Denies TMS?

The first step is understanding why the request was denied.

Sometimes the insurer needs additional documentation. In other cases, the insurer believes that a medical-necessity requirement has not been met.

If I believe TMS is clinically appropriate and there is a reasonable basis for challenging the decision, our office can pursue an appeal and provide additional supporting information.

If coverage ultimately is not available, an appropriate patient may choose to receive TMS on a self-pay basis.

What If I Don’t Have Insurance or My Insurance Won’t Cover TMS?

Houston West TMS offers a self-pay option for appropriate patients.

Our regular self-pay cost for a typical 36-treatment Deep TMS course, including initial mapping, is $7,400.

Limited-Time Self-Pay Rate

For appropriate patients who complete their psychiatric evaluation and schedule their first TMS treatment by January 15, 2027, we are offering:

First treatment, including initial mapping: $220

Each additional treatment: $165

A typical 36-treatment course totals $5,995.

That represents a savings of $1,405 compared with our regular self-pay cost.

Patients do not have to pay $5,995 upfront.

Payments can be made weekly as treatment is received. If treatment ends before 36 sessions, the patient pays only for treatments actually received.

The initial comprehensive psychiatric evaluation is billed separately.

Treatment may continue beyond January 15, 2027. To qualify for the promotional rate, the patient must complete the evaluation and schedule the first TMS treatment by that date.

My Approach to TMS and Insurance

I have practiced psychiatry long enough to remember when patients with treatment-resistant depression had relatively few options beyond trying additional medications or considering electroconvulsive therapy.

TMS has changed that conversation.

It is a noninvasive treatment option that does not require anesthesia or sedation. Patients can generally drive themselves home and return to their normal activities after treatment.

I am encouraged that access to TMS has improved and that some insurance requirements have become less burdensome.

At the same time, treatment decisions should not be dictated solely by an insurance checklist.

At Houston West TMS, I personally evaluate each prospective patient to determine whether TMS is appropriate.

I perform the initial mapping and motor-threshold determination, prescribe the treatment protocol and remain involved throughout treatment.

If TMS is not the right treatment, I will say so.

If TMS is appropriate but insurance initially denies coverage, we will determine whether there is a reasonable clinical basis for an appeal.

The goal is not simply to obtain an authorization.

The goal is to help each patient receive the treatment that makes the most clinical sense for that individual.

Find Out Whether Your Insurance Covers TMS

You do not have to determine your TMS benefits on your own.

Call Houston West TMS and provide your insurance information. Our office can help verify your benefits, explain the authorization process and identify the next steps.

Call today to schedule an evaluation or verify your TMS coverage.

Houston West TMS

902 Frostwood Drive, Suite 283

Houston, Texas 77024

713-464-4455

Medical and Insurance Disclaimer

This article is for general educational purposes and does not constitute individualized medical advice, diagnosis or treatment.

Insurance benefits, medical-necessity criteria, prior-authorization requirements, provider networks, deductibles, copayments and coinsurance vary by insurer and individual plan and may change.

Participation with an insurance company does not guarantee that Houston West TMS participates with every plan offered by that company or that TMS will be covered for a particular patient.

Coverage decisions are made by the patient’s insurer according to the applicable benefit plan and medical-necessity criteria.

References to particular insurers or authorization requirements are illustrative and should not be interpreted as a guarantee of coverage.

TMS candidacy and safety should be determined through an individualized medical and psychiatric evaluation.

A history of seizures, bipolar disorder, implanted medical devices or other medical conditions requires individual assessment and does not necessarily represent an absolute contraindication in every circumstance.

Self-pay pricing and promotional terms are subject to the stated eligibility requirements and may change.

References and Resources

1. Centers for Medicare & Medicaid Services. Local Coverage Determination L34998: Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive Disorder. Novitas Solutions.
2. Aetna. Clinical Policy Bulletin 0469: Transcranial Magnetic Stimulation and Cranial Electrical Stimulation.
3. U.S. Food and Drug Administration. BrainsWay Deep TMS System — FDA clearance and labeling information.
4. Levkovitz Y, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry. 2015;14(1):64-73.
5. Tendler A, et al. Deep TMS for major depression: large-scale real-world evidence and treatment outcomes. 2023.

Medically reviewed by William K. Drell, MD

Last medically reviewed: October 2026